Dr. Zeldis was appointed to our Board of Directors in June 2020. He is Executive Chair of ViralClear Pharmaceuticals, Inc. and previously served as Chief Medical Officer and President of Clinical Research, Medical Affairs, Drug Safety, Quality, and Regulatory at Sorrento Therapeutics, Inc. Prior to Sorrento he had a nearly 20-year career at Celgene during which he was instrumental in growing Celgene into one of the leading global biopharmaceutical companies. At Celgene, Dr. Zeldis held the position of Chief Medical Officer and Chief Executive Officer of Celgene Global Health. In that capacity, Dr. Zeldis oversaw multiple clinical trials using Celgene’s molecules. Dr. Zeldis trained in Internal Medicine at the UCLA Center for the Health Sciences and Gastroenterology at the Massachusetts General Hospital and Harvard Medical School. He was Assistant Professor of Medicine at the Harvard Medical School, Associate Professor of Medicine at University of California, Davis, Clinical Associate Professor of Medicine at Cornell Medical School and Professor of Clinical Medicine at the Robert Wood Johnson Medical School. He has published 123 peer reviewed articles and 44 US patents.